Biological and Pharmacological Activity of Plant Natural Compounds II
The Special issue "Biological and Pharmacological Activity of Plant Natural Compounds II" is continuing the intriguing research on the use of natural plant products. The second edition follows the aim of the first one.
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (338 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04571nam-a2201573z--4500 | ||
|---|---|---|---|
| 001 | 993545372004498 | ||
| 005 | 20231214132945.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202205s2022 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5680000000037513 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/81145 | ||
| 035 | |a (EXLCZ)995680000000037513 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Pezzani, Raffaele |4 edt | |
| 245 | 1 | 0 | |a Biological and Pharmacological Activity of Plant Natural Compounds II |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (338 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a The Special issue "Biological and Pharmacological Activity of Plant Natural Compounds II" is continuing the intriguing research on the use of natural plant products. The second edition follows the aim of the first one. | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Bergenia species | ||
| 653 | |a botanical description | ||
| 653 | |a traditional uses | ||
| 653 | |a phytochemistry | ||
| 653 | |a pharmacology | ||
| 653 | |a anti-urolithiatic activity | ||
| 653 | |a bergenin | ||
| 653 | |a Flaxseed oil | ||
| 653 | |a linusorb B3 | ||
| 653 | |a anti-cancer | ||
| 653 | |a apoptosis | ||
| 653 | |a actin polymerization | ||
| 653 | |a Src | ||
| 653 | |a glioblastoma | ||
| 653 | |a chlorogenic acid | ||
| 653 | |a coffee | ||
| 653 | |a cyclooxygenase | ||
| 653 | |a espresso | ||
| 653 | |a instant coffee | ||
| 653 | |a platelet aggregation | ||
| 653 | |a Rubia tinctorum L. | ||
| 653 | |a antioxidants | ||
| 653 | |a polyphenols | ||
| 653 | |a ethylene glycol | ||
| 653 | |a urolithiasis | ||
| 653 | |a histophatology | ||
| 653 | |a Saccharomyces cerevisiae | ||
| 653 | |a β-glucan | ||
| 653 | |a antimicrobial and anticancer activities | ||
| 653 | |a detoxification ability | ||
| 653 | |a immunomodulatory effect | ||
| 653 | |a Aquilaria sinensis | ||
| 653 | |a pheophorbide A | ||
| 653 | |a MMP-2 | ||
| 653 | |a MMP-9 | ||
| 653 | |a HT-1080 | ||
| 653 | |a advanced glycation end product (AGE) | ||
| 653 | |a oxidative stress | ||
| 653 | |a epithelial to mesenchymal transition | ||
| 653 | |a AGE-inhibitor | ||
| 653 | |a swertiamarin | ||
| 653 | |a diabetic nephropathy | ||
| 653 | |a astragaloside IV | ||
| 653 | |a Astragalus membranaceus | ||
| 653 | |a huang qi | ||
| 653 | |a Astragali Radix | ||
| 653 | |a liver | ||
| 653 | |a liver regeneration | ||
| 653 | |a 70% partial hepatectomy | ||
| 653 | |a proliferation | ||
| 653 | |a rat | ||
| 653 | |a memory | ||
| 653 | |a object recognition | ||
| 653 | |a Ginkgo biloba | ||
| 653 | |a dorsal hippocampus formation | ||
| 653 | |a brain-derived neurotrophic factor | ||
| 653 | |a Diclofenac | ||
| 653 | |a γ-lactone | ||
| 653 | |a nano-emulsion | ||
| 653 | |a methylcellulose | ||
| 653 | |a Ostrich oil | ||
| 653 | |a Struthio camelus | ||
| 653 | |a Caenorhabditis elegans | ||
| 653 | |a leaf extract | ||
| 653 | |a neuroprotection | ||
| 653 | |a antioxidant activity | ||
| 653 | |a DAF-16 | ||
| 653 | |a Clerodendrum infortunatum | ||
| 653 | |a terpenoids | ||
| 653 | |a phenylpropanoids | ||
| 653 | |a antidiabetic | ||
| 653 | |a breast cancer | ||
| 653 | |a Combretum indicum L. | ||
| 653 | |a antidiabetic activity | ||
| 653 | |a histopathology | ||
| 653 | |a UPLC-QTOF/ESI-MS | ||
| 653 | |a network pharmacology | ||
| 653 | |a Biebersteinia heterostemon | ||
| 653 | |a galegine | ||
| 653 | |a hypotensive | ||
| 653 | |a toxicity | ||
| 653 | |a Sage | ||
| 653 | |a Salvia officinalis | ||
| 653 | |a cytotoxicity | ||
| 653 | |a hepatoprotection | ||
| 653 | |a MDA | ||
| 653 | |a TAOxC | ||
| 653 | |a MCF-7 | ||
| 653 | |a HeLA cells | ||
| 653 | |a HepG-2 cells | ||
| 653 | |a Peganum harmala | ||
| 653 | |a anti-inflammatory activity | ||
| 653 | |a antioxidant | ||
| 653 | |a LC-ESI-MS/MS | ||
| 653 | |a traditional medicine | ||
| 653 | |a rheumatoid arthritis | ||
| 653 | |a rosmanol | ||
| 653 | |a carnosol | ||
| 653 | |a Callicarpa longissima | ||
| 653 | |a TLR4/NF-κB/MAPK | ||
| 653 | |a synergistic effect | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a anti-diabetic drugs | ||
| 653 | |a monoterpenes | ||
| 776 | |z 3-0365-3506-3 | ||
| 776 | |z 3-0365-3505-5 | ||
| 700 | 1 | |a Vitalini, Sara |4 edt | |
| 700 | 1 | |a Pezzani, Raffaele |4 oth | |
| 700 | 1 | |a Vitalini, Sara |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:37:54 Europe/Vienna |f system |c marc21 |a 2022-05-14 21:41:54 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337904130004498&Force_direct=true |Z 5337904130004498 |b Available |8 5337904130004498 | ||